Research programme: apelin receptor agonists - BioAge Labs
Latest Information Update: 27 Oct 2023
At a glance
- Originator BioAge Labs
- Class
- Mechanism of Action Apelin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Brain disorders
Most Recent Events
- 09 Oct 2023 Early research in Brain disorders in USA (unspecified route) (BioAge Labs pipeline, October 2023)